We performed a 3-year retrospective study of Streptococcus pneumoniae blood culture isolates recovered at Baragwanath Hospital, Soweto, South Africa, from 1993 to 1995. ] of 312 HIV-negative patients; P õ .001); this difference was found for both adults (19% vs. 4.3%; P õ .001) and children (53.3% vs. 30.2%; P õ .0343). Multiple resistance occurred more frequently in HIV-positive children (P Å .02). HIV-positive adults had a statistically significant increase in the percentage of serogroups and serotype usually found in children and commonly associated with antimicrobial resistance, i.e., serotype 14 and serogroups 6, 19, and 23 (48% vs. 28.6%; P õ .001). The increased prevalence of serogroups or serotypes usually found in children was also found among penicillin-susceptible strains. These data suggest that HIVinfected adults may again become susceptible to the serogroups or serotypes found in children.
Penicillin resistance in a clinically significant isolate of with AIDS was 9.4 cases per 1,000 patients per year in San Francisco, up to 100 times greater than before the AIDS Streptococcus pneumoniae was first observed in Australia in 1967; the isolate was recovered from the sputum of a patient epidemic. In a study from East Africa, S. pneumoniae was found to be the earliest and most common pathogen to cause with hypogammaglobulinemia [1] . In South Africa, penicillinresistant S. pneumoniae strains were first detected in Durban disease during HIV infection [10] . Invasive pneumococcal infection is the most common serious bacterial infection in in 1977, among patients with bacteremia, meningitis, pneumonia, and empyema [2] . In 1978, the occurrence of multiply HIV-infected children [8, 11] .
Rates of HIV infection and AIDS are increasing progresand highly resistant strains was reported in Johannesburg and Soweto [3] . Since then, there has been a progressive increase sively in South Africa. It was estimated that by the end of 1994, there were 1,100,000 HIV-infected people in South Africa, with in prevalence of penicillin-resistant strains causing systemic infection in South Africa, i.e., from 5% in 1979 to 14% in 1990 a doubling time of 15.5 months [12] . At Baragwanath Hospital, Soweto, the HIV seropositivity [4] . Worldwide spread of penicillin-resistant pneumococci has occurred [5, 6] . rate increased from 7.5% to 23.5% among adults selectively tested in medical wards and from 7.1% to 36% among children Bacterial pneumonia is more frequent in HIV-positive patients than in seronegative controls, and the rate of bacterial selectively tested in pediatric wards between January 1993 and January 1996. The HIV seropositivity rate among patients atpneumonia increases with decreasing CD4 lymphocyte counts [7] . S. pneumoniae is the leading cause of communitytending an antenatal clinic at the hospital increased from 2.4% to 11.6% between 1993 and 1995 (authors' unpublished data). acquired bacterial pneumonia [7] and associated bacteremia [8] in HIV-infected patients. Redd et al. [9] estimated that the The purpose of the present study was to investigate whether there was an association between penicillin-resistant pneumoincreased incidence of pneumococcal bacteremia in patients cocci in invasive bacteremic disease and HIV infection in our hospital and to evaluate the serogroups or serotypes involved. study at the hospital over a 3-year period, from January 1993 meningitis as well as bacteremia. The majority of patients had to December 1995, during which S. pneumoniae was isolated lower respiratory tract infection and bacteremia. The male-tofrom blood cultures of 1,012 inpatients, including 750 adults female ratio was 2.4:1 among adults, with a ratio of 3.6:1 and 262 children. The study group comprised 457 inpatients among HIV-negative adults and 1:1 among HIV-positive (45.2% of the total), 359 of whom were adults and 98 were adults. The male-to-female ratio was 2:1 among children, with children; HIV serostatus had been determined for all of these a ratio of 1.6:1 among HIV-negative children and 2.5:1 among patients.
HIV-positive children. The BACTEC system (Becton Dickinson, Sparks, MD) was Although the total number of medical patients and children used to determine growth in blood cultures. All strains were admitted to Baragwanath Hospital annually did not increase initially screened for antimicrobial susceptibility by the disk over the study period, the number of patients with pneumococdiffusion method on 5% blood agar plates with use of disks cal bacteremia increased from 321 in 1993 to 375 in 1995. containing 1 mg of oxacillin (Oxoid; Basingstoke, Hants, EnDespite a slight decline in the percentage of patients tested gland) to detect strains with reduced susceptibility to penicillin.
annually children, where 53.3% and 30.2% of strains were resistant The isolates were also serogrouped or serotyped on the basis in HIV-positive and HIV-negative children, respectively of the Quellung reaction, as determined with specific pneumo-(P Å .034; OR Å 2.64; 95% CI Å 1.07 -6.61). coccal antisera (Statens Seruminstitut, Copenhagen).
Antimicrobial susceptibility patterns are shown in table Nosocomial bacteremia was defined as detection of pneumo-2. Strains resistant to penicillin alone were most common. cocci in blood culture ú48 hours after admission to hospital.
Multiple resistance (resistance to at least three different HIV testing was performed by using the recombinant HIV classes of antibiotics) also occurred, particularly among the 1 and 2 third-generation EIA (Abbott Diagnostic Products, children. Tetracycline resistance alone occurred more comWiesbaden, Germany), and the results were confirmed by westmonly in adults. ern blot in 1993 and by a second EIA (Enzygnost HIV-1/2;
The penicillin MICs for resistant strains tested in adults and Behring Diagnostics, Marburg, Germany) in 1994 and Wellcochildren are indicated in table 3. MICs varied from 0.12 zyme HIV 1 / 2 (Murex Diagnostics, Dartford, UK) in 1995.
mg/mL to 4 mg/mL, with the majority of strains in the intermeAdditional confirmatory tests for children õ15 months of age diate category (MICs, 0.12 mg/mL -1 mg/mL) for both HIVwere not performed in this study, and all HIV-positive children positive and HIV-negative patients. High-level resistance ocwith invasive pneumococcal disease were assumed to be HIV curred in 3 (0.83%) of 359 adults and 6 (6.1%) of 98 children. infected.
The penicillin MICs were 2 mg/mL in all cases except one (a Statistical analysis was performed with use of the x 2 square child with meningitis), where the MIC was 4 mg/mL. test to evaluate differences between groups. Stratified analysis
The results of serogrouping or serotyping of S. pneumoniae was carried out by using the Mantel-Haenszel x 2 estimate. strains in adults and children are summarized in figure 1. FourOdds ratios and 95% confidence intervals were calculated.
teen of the strains (9 from adults and five from children) lost Results viability before testing. Twenty-one of 90 serogroups or serotypes were represented. The most common type was serotype Of the 457 patients in the group studied, 22 (6.1%) of the 359 adults and 9 (9.2%) of the 98 children had pneumococcal 1 in HIV-negative adults (100 patients [38.6%]) followed by / 9c3f$$no53 10-24-97 08:32:10 cida UC: CID , and serogroup 6 (13%). The reduction in the incidence of serotype 1 resistance was accompanied by clindamycin resistance in all cases except one. TMP-SMZ susceptibility testing of all isowas statistically significant (P Å .0013; OR Å 0.40; 95% CI Å 0.22 -0.71). Of HIV-positive adults, 48% were infected lates was begun in 1995, and 5.8% (7 of 120) were found to be resistant. Resistance to cefotaxime or ceftriaxone, based on with serogroups common among children (i.e., 6, 19, 23 and serotype 14), whereas 28.6% of HIV-negative adults were in-MIC determinations, was less common; resistance to these drugs occurred in seven patients (1.5%; five children and two fected with these serogroups (table 4). This finding was also significant (P õ .001; OR Å 2.31; 95% CI Å 1.39 -3.82).
adults), all of whom except one child were HIV positive. The resistance was intermediate (MIC, 1 mg/mL) in the adults and In adults with penicillin-susceptible strains, a greater variety of serogroups or serotypes occurred in HIV-negative patients in two children, and high-level (MIC, 2 mg/mL) in three children (two were infected with serogroup 23, and one was inthan in HIV-positive patients (figure 1). There was a trend towards an increase in the percentage of ''pediatric'' serotypes fected with serogroup 19). Overall resistance to each of the antimicrobial agents tested among HIV-positive patients (30 [37.0%] of 81 patients) vs. HIV-negative patients (63 [25.4%] of 248), and this difference was higher among children than among adults. This finding also applied to TMP-SMZ; 3 (3.2%) of 94 isolates in adults was statistically significant (P Å .04; OR Å 1.73; 95% CI Å 0.98 -3.05). Among adults with penicillin-resistant strains, the were resistant, and 4 (15.3%) of 26 isolates in children were resistant. The rates of resistance to all antimicrobials, except serogroups recovered were similar (serogroups 6, 14, and 19) for HIV-negative and HIV-positive patients, although serotetracycline and rifampin, were higher among HIV-positive children than among HIV-negative children. The increase in group 6 was the most common serogroup in HIV-negative adults, and serogroup 19, followed by serotype 14, was most rates of resistance to erythromycin and chloramphenicol among HIV-positive children did not reach statistical significance. common in HIV-positive adults. Serogroups 9 and 23 were also represented among HIV-positive adults.
Rates of resistance to erythromycin and rifampin were increased among HIV-positive adults vs. HIV-negative adults, Serogroup 6 was the most common serogroup isolated among HIV-negative children, (35.8% of isolates), followed but rates of resistance to tetracycline were not. Rates of resistance to chloramphenicol, cefotaxime, and ceftriaxone were by 14 and 19 (11.3% of strains each; figure 1 ). In HIV-positive children, serogroups 6 and 23 and serotype 14 each accounted very low among adults. Multiple resistance, defined as resistance to at least three for 20% of strains. Although the percentage of ''pediatric'' serogroups increased from 62.2% to 73.3%, this increase was different classes of antibiotics, occurred in 12 (26.7%) of 45 HIV-positive children vs. 5 (9.4%) of 53 HIV-negative chilnot statistically significant. Approximately the same percentage of these serogroups and serotype occurred among penicillindren. This difference was statistically significant (P Å .02; OR Å 3.42; 95% CI Å 0.99 -12.44). Multiple resistance insusceptible strains, although serogroup 6 was less frequent in HIV-positive children. Among penicillin-resistant strains, serocluded resistance to penicillin in 18 (78%) of 23 resistant isolates overall; however, this rate was 100% for isolates from group 6 was most common in HIV-negative children (50% of isolates), while serogroup 23 was most common in HIV-posichildren. Fifty percent (12 of 24) and 31.3% (5 of 16) of all isolates recovered from HIV-positive children and HIVtive children (33.3%). Of the penicillin-susceptible strains, serogroup 6 was still most common (29.7% of isolates) in HIVnegative children, respectively, were multidrug resistant. The most common pattern was resistance to penicillin, chloramnegative children, while serotype 1 was most common (33.3%) in HIV-positive children; serogroups 6 and 19 and serotype 14 phenicol, and tetracycline. This pattern occurred with or without resistance to erythromycin and clindamycin, TMP-SMZ, were equally represented (14.3% of isolates).
/ 9c3f$$no53
10-24-97 08:32:10 cida UC: CID rifampin, and third-generation cephalosporins. Among multiserogroup 23 and one with serotype 14]). Six of these infections occurred in HIV-negative children (three isolates of serogroup drug-resistant isolates, serogroups 19 and 23 and serotype 14 were represented most often. Resistance to TMP-SMZ was 6 and one each of serotype 14, serogroup 19, and serogroup 23). Only four of the strains were highly resistant, and all of associated with multiple resistance in three of seven cases (an HIV-positive adult infected with serogroup 19 and two HIVthese were detected in children: three of these were multiply resistant serogroup 23 (two of which were recovered from HIVpositive children infected with serogroups 19 and 23). Multiple resistance seldom occurred in either HIV-positive or HIV-negapositive children) and one was multiply resistant serotype 14, recovered from an HIV-negative child. One of the children tive adults (table 2) .
The majority of strains of S. pneumoniae in this study were with serogroup 23 also developed meningitis. Five penicillinsusceptible pneumococcal bacteremic infections were acquired community acquired. Nosocomial spread of pneumococci occurred in 15 patients (12 children and 3 adults). Ten penicillinin the hospital during the same period: two in adults (one HIVnegative patient infected with serotype 1 and one HIV-positive resistant pneumococcal bacteremic infections (nine of which were in children) were acquired in the hospital over the patient infected with serogroup 6) and three in HIV-negative children (two infected with isolates of serotype 1 and one 3-year period. Four of these infections occurred in HIV-positive patients (one adult [serogroup 19] and three children [two with infected with serogroup 6).
/ 9c3f$$no53 10-24-97 08:32:10 cida UC: CID resistance was associated with HIV seropositivity. This finding may reflect local antibiotic usage in Nairobi. Penicillin resistance was higher among children than among Discussion adults, as has been described previously [5] . This difference We found a significant association between penicillinresistant pneumococcal bacteremia and HIV seropositivity in the group of adults and children we evaluated. This finding is in keeping with findings for adults in Kenya [15] and for children in the United States with invasive pneumococcal infections [11] .
Among HIV-infected adults, there was a significant trend towards a greater proportion of infections due to serogroups 6, 19, and 23 and serotype 14, which are commonly found in children. These strains are often associated with resistance and represent the majority of resistant pneumococci isolated worldwide [5] and in South Africa [4] .
It has been shown that penicillin-resistant pneumococci occur more often in patients who have received prior b-lactam antibiotic therapy, have been hospitalized during the 3 months before the infection, or have had previous episodes of pneumonia [16] . It was not possible to obtain accurate information regarding these issues in our retrospective study. Selective pressure by penicillin may have occurred, since penicillin and amoxicillin are inexpensive and are the most commonly used antimicrobial agents in Soweto clinics. Penicillin may be used more frequently in HIV-infected patients who have multiple bacterial infections.
Selective pressure by other antibiotics, such as TMP-SMZ, could play a role in the emergence of resistant pneumococci. In a study on hospitalized HIV-infected adults in France, treatment with antibacterial agents, particularly TMP-SMZ, in the previous 3 months was found to be associated with an increased risk of isolation of pneumococci with reduced susceptibility to penicillin, suggesting that long-term therapy with TMP-SMZ might promote the selection of penicillin-resistant pneumococci [17] . A significant association between carriage of penicillinresistant pneumococci and recent consumption of TMP-SMZ was shown in children [18] . In the 26% of our strains that were [19] . These pediatric serogroups colonize children earlier than do other serogroups [5] and are carried for longer of nasopharyngeal carriage, are relatively more common [21] . However, in contrast to data from South America, we found periods (mean period, 4.2 months vs. 2.7 months for all other serogroups combined; P õ .01) [19] . These serogroups are that serotype 5 was relatively unimportant (isolated from 1.5% of patients) but that serogroup 6 was the second most important poorly immunogenic in young children õ2 years of age and sometimes in those £5 years of age [20] . Pneumococcal caroverall (isolated from 19.6% [62 of 457] of patients).
The rapid falloff of relative risk of serotype 14 that has been riage has been correlated with the emergence of clinical disease: of new strains acquired by children, 15% were found to described in the second decade of life [21] did not occur in our study. Serotype 14 constituted 12.9% (59 of 457) of the result in disease before the HIV epidemic [19] . A reduction in risk of disease occurs after the first decade of life, in accordance total percentage of isolates (12.3% in adults), and serogroups 19 and 23 became relatively more important, comprising 9% with maturing antibody responses [21] .
The significant shift towards an increase in the serogroups and 3%, respectively, of the total percentage of isolates. Overall, this represented a significant shift towards the serogroups common in children (serogroups 6, 19, and 23 and serotype 14) in HIV-positive adults with penicillin-susceptible strains commonly found in children.
The progressively increasing rate of pneumococcal bactermay be due to characteristics of these groups/types that are unrelated to resistance determinants or additional antibiotic seemia associated with HIV infection seen at our hospital has been observed elsewhere. An increase in the rate of bacteremic lection pressure (i.e., it may reflect a loss of immunity to these pneumococci that had been acquired in childhood). However, and nonbacteremic S. pneumoniae infections, which almost doubled during the period 1987 -1992, was noted in a hospital this shift may also be influenced by strains with reduced zones of inhibition on disk susceptibility testing for which MICs are in Madrid and was partially attributable to HIV infection [25] . The association of HIV seropositivity with penicillinin the susceptible range of 0.03 -0.06 mg/mL [22] .
Intrafamilial carriage of a single type of S. pneumoniae and resistant pneumococci and multidrug resistance may have adverse consequences in terms of morbidity and mortality. Strains spread of the organism to more than one family member have been reported to be common, often occurring in association with intermediate resistance to penicillin are not thought to be of clinical significance, except in cases of meningitis in with an upper respiratory tract infection [23] . It is likely that resistant pneumococcal strains are spreading within HIVimmunocompetent patients. Our empirical therapy for community-acquired pneumonia is in keeping with local guidelines infected families, particularly between parent and child. They may be spread more frequently from child to immunocom-(i.e., parenteral penicillin or parenteral ampicillin), and these guidelines have not been influenced by the current prevalence promised parent than vice versa. If children are a source of infection, they are likely to transmit one of the common seroof intermediately penicillin-resistant pneumococci [26] . The response in HIV-infected patients with resistant pneumococcal groups/serotypes (6, 14, 18, 22, or 25) carried in the nasopharynx. Spread from infants and young children to HIV-infected isolates has not been adequately studied. Successful treatment with conventional penicillin dosages has been achieved in some mothers during repeated close contact could explain the higher incidence of invasive resistant strains among HIV-positive cases of intermediate resistance [10, 27] . Clinicians should be guided by individual patients' clinical responses to therapy, and women (male-to-female ratio Å 1:1), than among HIV-negative women (male-to-female ratio Å 3.6:1).
moderately increased dosages of penicillin may be required, particularly in patients who are immunocompromised and in The finding of serotype 1 as the most common invasive serotype in 28.9% (132 of 457 strains) is in keeping with a those with accompanying bacteremia and an increased bacterial / 9c3f$$no53 10-24-97 08:32:10 cida UC: CID load. A recommendation for treatment with high-dose penicillin The other option is increased use of pneumococcal polysaccharide vaccine in HIV-infected patients early in the course of has been made for patients infected with intermediately penicillin-resistant strains causing pneumonia in Spain [28] .
infection, even though efficacy data are limited [30] . Most of the pneumococci isolated from the adults in our study are Nonmeningitic infections due to penicillin-resistant pneumococci (MIC, §2 mg/mL) can be treated with high-dose penicilrepresented in the 23-valent polysaccharide vaccine for adults, and 85 (86.7%) of the 98 isolates from the children in our study lin G (10 mg/kg every 2 hours; 180,000 -200,000 m/[kgrd]), third-generation cephalosporins, vancomycin, or other antimiare represented in the 9-valent conjugate vaccine (serogroups or serotypes 1, 4, 5, 6, 9, 14, 18, 19, and 23) for children (41 crobial agents according to susceptibility. Our own experience has been limited largely to strains for which the MICs were 2
[91%] of 45 HIV-positive children). The use of the more immunogenic conjugate vaccines in children õ2 years of age may mg/mL. For higher levels of penicillin resistance, alternative agents are preferred. It is not clear whether the response to be of value and should be tested in clinical trials. Even if the antibody levels generated are suboptimal and are not sustained, penicillin therapy will be adequate in immunocompromised AIDS patients with penicillin-resistant strains, since outcome the occurrence of invasive pneumococcal infections may be reduced. may be influenced by the underlying disease.
The increase in the frequency of intermediately penicillinresistant strains is significant in terms of the treatment of men-
